| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
119,920,000 |
| Market
Cap: |
2.49(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.96 - $32.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Denali Therapeutics is a biopharmaceutical company that discovers and develops therapeutics to defeat neurodegenerative diseases. Co.'s clinical-stage programs are: leucine-rich repeat kinase 2 inhibitor program to address Parkinson's disease; enzyme transport vehicle :IDS program, its lead brain-penetrant enzyme replacement therapy, enabled by its enzyme transport vehicle, which is designed to restore iduronate 2-sulfatase, and reduce glycosaminoglycans, both peripherally and in the brain, in patients with mucopolysaccharidosis II; and eukaryotic initiation factor 2 B activator program to address diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
97,298 |
194,789 |
253,657 |
527,733 |
| Total Sell Value |
$1,992,536 |
$3,809,170 |
$5,326,320 |
$13,514,934 |
| Total People Sold |
3 |
6 |
6 |
7 |
| Total Sell Transactions |
4 |
19 |
39 |
77 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ho Carole |
Chief Medical Officer |
• – – |
2019-01-03 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
8,552 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-01-03 |
4 |
AS |
$18.89 |
$114,285 |
I/I |
(6,050) |
2,658,871 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
178,125 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
OE |
$5.28 |
$30,492 |
I/I |
5,775 |
183,900 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2019-01-02 |
4 |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
142,615 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2019-01-02 |
4 |
AS |
$19.42 |
$118,311 |
I/I |
(6,050) |
2,664,921 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2018-12-12 |
4 |
AS |
$20.80 |
$52,000 |
I/I |
(2,500) |
677,589 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2018-12-11 |
4 |
AS |
$20.22 |
$50,550 |
I/I |
(2,500) |
680,089 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2018-12-10 |
4 |
AS |
$20.18 |
$50,450 |
I/I |
(2,500) |
682,589 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
178,125 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
OE |
$5.28 |
$92,400 |
I/I |
17,500 |
195,625 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-12-03 |
4 |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
148,390 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2018-12-03 |
4 |
AS |
$18.42 |
$337,938 |
I/I |
(18,333) |
2,670,971 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2018-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
40,000 |
2,689,304 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
178,125 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
OE |
$5.28 |
$64,601 |
I/I |
12,235 |
195,625 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-11-15 |
4 |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
165,890 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2018-11-15 |
4 |
AS |
$18.12 |
$246,236 |
I/I |
(13,588) |
2,729,304 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2018-11-13 |
4 |
AS |
$18.00 |
$85,428 |
I/I |
(4,746) |
2,742,892 |
|
- |
|
| Schuth Alexander O. |
COO and Secretary |
• – – |
2018-10-02 |
4 |
OE |
$5.28 |
$62,498 |
D/D |
7,043 |
12,961 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2018-10-01 |
4 |
AS |
$21.72 |
$398,193 |
I/I |
(18,333) |
2,747,638 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-10-01 |
4 |
AS |
$21.72 |
$380,100 |
I/I |
(17,500) |
183,390 |
|
- |
|
| Watts Ryan J. |
President and CEO |
• • – |
2018-09-04 |
4 |
AS |
$19.06 |
$349,427 |
I/I |
(18,333) |
2,765,971 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-09-04 |
4 |
AS |
$19.05 |
$333,375 |
I/I |
(17,500) |
200,890 |
|
- |
|
| Ho Carole |
Chief Medical Officer |
• – – |
2018-08-29 |
4 |
AS |
$18.04 |
$315,700 |
I/I |
(17,500) |
218,390 |
|
- |
|
416 Records found
|
|
Page 16 of 17 |
|
|
1.39 (6.28%) 
